255
3
3
1819
Cat. No. | Product Name | ||
---|---|---|---|
L9830 | 抗帕金森病化合物库 | 857 compounds | |
857 种帕金森病相关的化合物集合,可用于高通量和高内涵筛选; | |||
L2191 | 抗乳腺癌化合物库 | 1939 compounds | |
1939 种与乳腺癌相关的化合物,可以用于抗乳腺癌药物研发和药理研究; | |||
L9840 | 抗阿尔茨海默症化合物库 | 986 compounds | |
986 种阿尔茨海默症相关的化合物集合,可用于高通量和高内涵筛选; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9651 |
PD-1/PD-L1-IN-9
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1/PD-L1-IN-9 是一种有效和具有口服活性的 PD-1/PD-L1 相互作用抑制剂,IC50 值为 3.8 nM。PD-1/PD-L1-IN-9 可以增强免疫细胞对肿瘤细胞的杀伤活性。PD-1/PD-L1-IN-9 在 CT26 小鼠模型中表现出显着的体内抗肿瘤活性。 | |||
T9616 |
PD-1/PD-L1-IN-10
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1/PD-L1-IN-10 是一种口服有效的PD-1/PD-L1抑制剂 (IC50of 2.7 nM),显示出抗肿瘤活性。 | |||
T12379 |
PD-1-IN-22
|
Others; PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation; Others |
PD-1-IN-22 是一种有效的程序性细胞死亡 1 (PD-1)/程序性细胞死亡配体1 (PD-L1) 相互作用的抑制剂,IC50 为 92.3 nM。 | |||
T35394 |
Sintilimab (anti-PD-1)
IBI308,Sintilimab (anti-PD-1) |
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
Sintilimab (IBI308) 是一种人源化的 IgG4 单克隆抗体,具有显著的抗肿瘤活性,通过与 PD-1 结合从而阻断 PD-1 与其配体 (PD-L1 和 PL-L2) 的相互作用,进而恢复内源性抗肿瘤 T 细胞反应。Sintilimab 联合其他化合物来治疗经典霍奇金淋巴瘤、非小细胞肺癌和食管癌。 | |||
T3655 |
BMS-1
PD1-PDL1 inhibitor 1,PD-1/PD-L1 inhibitor 1 |
Apoptosis; PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
BMS-1 (PD-1/PD-L1 inhibitor 1)是一种 PD-1/PD-L1蛋白质/蛋白质相互作用的抑制剂,IC50为 6 到 100 nM。 | |||
T36899 |
INCB086550
PD-1/PD-L1-IN-8 |
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
INCB086550 (PD-1/PD-L1-IN-8) (example 24) 是 PD-1/PD-L1 的抑制剂,其IC50 值为 <= 10 nM。 | |||
T36900 |
PD-1/PD-L1-IN-NP19
PD-1/PD-L1-IN-NP19 |
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1/PD-L1-IN-NP19 是 PD-1/PD-L1 的抑制剂,抑制人类 PD-1/PD-L1 相互作用的 IC50 值为 12.5 nM。PD-1/PD-L1-IN-NP19 可以激活肿瘤的免疫微环境,这可能有助于其抗肿瘤作用。 | |||
T36487 |
Evixapodlin
PD-1/PD-L1-IN 7,GS-4224 |
Antiviral; HBV; PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation; Microbiology/Virology |
Evixapodlin (PD-1/PD-L1-IN 7) 是一种人 PD-1/PD-L1蛋白/蛋白相互作用抑制剂(IC50:0.213)。Evixapodlin 具有抗癌和抗病毒活性。 | |||
T40112 |
PROTAC PD-1/PD-L1 degrader-1
PROTAC PD-1/PD-L1 degrader-1 |
||
PROTAC PD-1/PD-L1 degrader-1, a Cereblon E3 ligand-based compound, is a PD-1/PD-L1 PROTAC that effectively inhibits the interaction between PD-1 and PD-L1 with an IC50 value of 39.2 nM. It successfully restores the suppressed immune response in a co-culture model consisting of Hep3B/OS-8/hPD-L1 cells and CD3 T cells. Additionally, this compound moderately decreases PD-L1 protein levels through a lysosome-dependent mechanism. | |||
T5410 |
PD158780
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
PD158780是一种EGFR 家族抑制剂,对EGFR、ErbB2、ErbB3和ErbB4的IC50值分别为8 μM、49、52 和 52 nM。 | |||
T4696 |
BMS202 hydrochloride (1675203-84-5(free base))
PD-1/PD-L1 inhibitor 2 hydrochloride |
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
BMS202 hydrochloride (1675203-84-5(free base)) (PD-1/PD-L1 inhibitor 2 hydrochloride) 是一种小分子 PD-1/PD-L1 相互作用抑制剂 (IC50: 18 nM)。生物物理研究表明 BMS202 直接与 PD-L1 结合。 BMS202 的结合促进 PD-L1 二聚化并阻断 PD-L1/PD1 相互作用。 | |||
T12380 |
PD-1/PD-L1-IN 5 TFA
PD-1/PD-L1-IN 5 |
Others | Others |
PD-1/PD-L1-IN 5 is an inhibitor of PD-1/PD-L1 protein/protein interaction (IC50 of ≤100 nM). | |||
T26859 |
BMS-8
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
BMS-8 抑制PD-1/PD-L1相互作用(IC50:7.2 μM)。它能够直接与 PD-L1 结合,促使形成 PD-L1 同源二聚体,进而阻断 PD-L1 与 PD-1 的相互作用。 | |||
T3146 |
BMS-202
PD1-PDL1 inhibitor 2,PD-1/PD-L1 inhibitor 2 |
Apoptosis; PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
BMS-202 (PD1-PDL1 inhibitor 2) 是一种非肽类 PD-1/PD-L 复合物抑制剂,其 IC50为 18 nM,KD 为 8 μM。它与 PD-L1 直接结合并阻断人类 PD-1/PD-L 的相互作用,具有抗肿瘤活性。 | |||
T35396 | Spartalizumab (anti-PD-1) | PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
Spartalizumab (anti-PD-1)是一种针对PD-1的人源IgG4抗体,抑制PD-L1和PD-L2与PD-1的结合。PDR001可与PD-1以高亲和力结合,抑制其生物活性;MW: 145.8 KD。 | |||
T6136 |
Canertinib
PD-183805,CI-1033,卡纽替尼 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Canertinib (CI-1033) 是有效地,不可逆的EGFR 抑制剂;抑制细胞EGFR 和ErbB2自身磷酸化的IC50值分别为7.4和9 nM。 | |||
T6932 |
PD168393
|
Apoptosis; EGFR; FGFR; IGF-1R; PDGFR; PKC; Autophagy | Angiogenesis; Apoptosis; Autophagy; Chromatin/Epigenetic; Cytoskeletal Signaling; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
PD168393 是一种细胞渗透性的选择性 EGFR 酪氨酸激酶和 ErbB2的抑制剂。它不可逆转地失活 EGF 受体,IC50值为 0.7 nM,但对胰岛素受体、PDGFR、FGFR 和 PKC 无作用。 | |||
T39904 | PD-1-IN-24 | ||
PD-1-IN-24 (compound 1) is an orally active PD-1 inhibitor. | |||
T12386 | PD-1-IN-18 | Others | Others |
PD-1-IN-18 is a PD1 inhibitor of signaling pathway, and acts as an immunomodulator. | |||
T12377 |
PD-1-IN-17
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1-IN-17 是程序性细胞死亡 1 (PD-1) 的抑制剂。 PD-1-IN-17 在 100 nM 时抑制 92% 的脾细胞增殖。 | |||
T12378 | PD-1-IN-20 | Others | Others |
PD-1-IN-20 is the less active enantiomer of PD-1-IN-1. | |||
T23127 |
PD-161570
PD 161570 |
EGFR; FGFR; PDGFR; Src | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
PD-161570 是一种有效的 ATP 竞争性人 FGF-1 受体抑制剂,IC50 为 39.9 nM,Ki 为 42 nM。它还是骨形态发生蛋白 (BMPs) 和TGF-β信号抑制剂。它抑制PDGF 刺激的自磷酸化和FGF-1受体磷酸化,IC50分别为 450 和 622 nM。它抑制 PDGFR、EGFR 和 c-Src 酪氨酸激酶,IC50 值分别为 310、240 和 44 nM。 | |||
TP1463 |
PD-1/PD-L1-IN 3 TFA (1629654-95-0 free base)
PD-1/PD-L1-IN 3 TFA |
||
PD-1/PD-L1-IN 3 TFA inhibits the binding of human PD-1 to PD-Ll with an IC50 of 9 nM. | |||
T8976 |
PD-089828
|
EGFR; FGFR; PDGFR; Src | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
PD-089828 是受体酪氨酸激酶 FGFR1、PDGFRβ 和 EGFR 的竞争性抑制剂,IC50分别为0.15、1.76 和 5.47 µM。它也是非受体酪氨酸激酶 c-Src 的非竞争性抑制剂,IC50 为 0.18 µM。 | |||
T2501 |
Canertinib dihydrochloride
CI-1033 dihydrochloride,PD-183805 dihydrochloride,Canertinib,卡奈替尼二盐酸盐 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Canertinib dihydrochloride (PD-183805 dihydrochloride) 是一种可口服的喹唑啉盐酸盐,具有潜在的抗肿瘤和放射增敏活性,抑制细胞 EGFR 和 ErbB2自身磷酸化的 IC50值分别为 7.4 和 9 nM。 | |||
T21737L |
PD-1/PD-L1 Inhibitor 3 acetate (1629654-95-0 Free base)
|
||
PD-1/PD-L1 Inhibitor 3 acetate (1629654-95-0 Free base) 抑制人 PD-1 与 PD-L1 的结合,IC50 为 9 nM。 | |||
T12377L |
PD-1-IN-17 (TFA) (1673560-66-1 free base)
PD-1-IN-17 (TFA) |
Others | Others |
PD-1-IN-17 TFA is a inhibitor of programmed cell death-1 (PD-1) . | |||
T2041 |
PD153035
NSC 669364,SU-5271,ZM 252868,AG1517 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
PD153035 (NSC-669364) 是一种EGFR 抑制剂,Ki 和IC50值分别为6和25 pM。 | |||
T78269 |
Anti-Mouse PD-1 Antibody (RMP1-14)
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
RMP1-14 是一种 IgG1 样免疫球蛋白抗小鼠 PD-1 抗体,可阻断 PD-1/PD-L1 信号传导。 | |||
T1761 |
PD153035 hydrochloride
ZM 252868 HCl,AG 1517,Tyrphostin AG 1517,SU 5271,PD153035 HCl,ZM 252868 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
PD153035 hydrochloride (ZM 252868) 是有效地EGFR 抑制剂,Ki 和IC50值分别为6和25 pM。 | |||
T22674 |
Co 101244 hydrochloride
Co 101244盐酸盐,4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride |
NMDAR | Neuroscience |
Co 101244 hydrochloride (4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride) 是一种含有 NR2B 的 NMDA 受体拮抗剂。 | |||
T12378L |
CA-170
PD-1-IN-1 |
Others | Others |
PD-1-IN-1 is a programmed cell dealth-1inhibitor. PD-1-IN-1 can be used as an immune modulator. | |||
T31424 |
DIBA
PD022551,NSC 654077,DIBA-1,PD-22551,DIBA (Antineoplastic) |
||
DIBA is an ER zinc finger inhibitor that inhibits ligand-dependent and non-dependent cell growth in TAM resistant breast cancer in vitro and in vivo. | |||
T72724 | PD-1/PD-L1-IN-30 | ||
PD-1/PD-L1-IN-30 是一种 PD-1/PD-L1结合抑制剂,IC50值为 0.018 μM。PD-1/PD-L1-IN-30 可用于癌症及其他相关疾病的研究。 | |||
T61968 | PD-1/PD-L1-IN 6 | ||
PD-1/PD-L1-IN 6 (compound A13) 是有效的PD-1/PD-L1相互作用抑制剂(IC50为 132.8 nM)。PD-1/PD-L1-IN 6 显示出显著的免疫调节活性。 在 Hep3B/OS-8/hPD-L1 与 CD3 T 细胞共培养模型中,PD-1/PD-L1-IN 6显著提高干扰素 -γ 分泌,且无明显毒性作用。 在 T 细胞-肿瘤共培养模型中,PD-1/PD-L1-IN 6恢复免疫应答。 | |||
T72670 |
PD-1/PD-L1-IN-13
|
||
PD-1/PD-L1-IN-13 是一种有效的免疫检查点 PD-1/PD-L1抑制剂,对 PD-1/PD- L1 相互作用的 IC50值为 10.2 nM。PD-1/PD-L1-IN-13 在 Hepa1-6 同系小鼠模型中促进 CD8+T 细胞活化并延缓肿瘤生长。 | |||
T72680 | PD-1/PD-L1-IN-27 | PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1/PD-L1-IN-27是一种针对PD-1/PD-L1的有效抑制剂,具有134 nM的IC50值。该化合物表现出具有低T细胞毒性的抗肿瘤活性,并能够激活CD8+T细胞以及减少T细胞耗竭。 | |||
T72691 |
PD-1/PD-L1-IN-28
|
||
PD-1/PD-L1-IN-28(化合物3),一种针对PD-1/PD-L1信号通路的免疫检查点抑制剂,具IC50值为0.744 µM,展现出在肿瘤免疫治疗领域的研究潜力。 | |||
T79576 |
PD-1/PD-L1-IN-32
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1/PD-L1-IN-32(compound A56)为高效抗PD-1/PD-L1抑制剂,IC50值为2.4 nM,显示出抗癌活性。在hPD-L1 MC38人源化小鼠模型中,该化合物能显著抑制肿瘤生长,同时对小鼠未见明显毒性。 | |||
T64086 |
PD-1/PD-L1-IN-20
|
||
PD-1/PD-L1-IN-20 是一种小分子的 PD-1/PD-L1蛋白-蛋白相互作用抑制剂。PD-1/PD-L1-IN-20 可阻断 PD-1/PD-L1 相互作用 (IC50: 5.29 nM)。PD-1/PD-L1-IN-20 能够用于研究癌症、传染病和自身免疫性疾病。 | |||
T63329 | PD-1/PD-L1-IN-25 | ||
PD-1/PD-L1-IN-25 是一种 PD-1/PD-L1 互作的抑制剂 (IC50: 16.17 nM),可有效激活 PBMCs 中 T 细胞的抗肿瘤免疫。PD-1/PD-L1-IN-25 能够用于研究癌症。 | |||
T63614 | PD-1/PD-L1-IN-15 | ||
PD-1/PD-L1-IN-15 是 PD-1/PD-L1 的有效抑制剂 (IC50: 60.1 nM),对肿瘤免疫治疗表现出研究潜力。 | |||
T72675 |
PD-1/PD-L1-IN-23
|
||
PD-1/PD-L1-IN-23为一种高效的口服活性PD-1/PD-L1抑制剂,是L7酯类的前药形式。L7为苯并[c][1,2,5]恶二唑衍生物,作为PD-L1抑制剂在生物学上进行评估。PD-1/PD-L1-IN-23在同基因和PD-L1人源化小鼠的肿瘤模型中展现出显著的抗肿瘤效果。 | |||
T72721 | PD-1/PD-L1-IN-29 | ||
PD-1/PD-L1-IN-29(S4-1),有效PD-1/PD-L1抑制剂,IC50值为6.1 nM。能够结合PD-L1,破坏PD-1/PD-L1相互作用,诱导PD-L1二聚化与内化,有助于改善其对内质网的定位并促进PD-L1进入内质网,展现出抗癌活性。 | |||
T63948 | PD-1/PD-L1-IN-16 | ||
PD-1/PD-L1-IN-16 是 PD-1/PD-L1 的有效抑制剂 (IC50: 53.2 nM),对肿瘤免疫治疗表现出研究潜力。 | |||
T79205 | PD-1/PD-L1-IN-34 | PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
PD-1/PD-L1-IN-34(化合物(1S,2S)-A25)能有效地抑制PD-1/PD-L1相互作用,其IC50值为0.029 μM,表现出对PD-L1的选择性结合亲和力,KD值为0.1554 μM。该化合物通过激活免疫微环境来抑制肿瘤生长。 | |||
T39588 |
Human PD-L1 inhibitor IV
Human PD-L1 inhibitor IV |
||
Human PD-L1 inhibitor IV is a polypeptide compound that competitively inhibits the human PD-1 protein. It has a Kd value of 1.38 μM and effectively blocks the interaction between hPD-1 and hPD-L1. | |||
T39591 |
Human PD-L1 inhibitor I
Human PD-L1 inhibitor I |
||
Human PD-L1 inhibitor I is a peptide ligand that specifically inhibits the interaction between human PD-L1 and human PD-1. It exhibits a KD value of 3.39 μM, indicating its binding affinity. The presence of Human PD-L1 inhibitor I disrupts the binding between human PD-L1 and human PD-1, thereby attenuating their respective functions. | |||
T39589 |
Human PD-L1 inhibitor III
Human PD-L1 inhibitor III |
||
Human PD-L1 inhibitor III is a human PD-L1 inhibitor. | |||
T39590 |
Human PD-L1 inhibitor II
Human PD-L1 inhibitor II |
||
Human PD-L1 inhibitor II is a potent PD-L1 inhibitor with anti-cancer activity. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1051 |
1-Caffeoylquinic acid
金银花,1-咖啡酰奎宁酸 |
NF-κB | NF-κB |
1-Caffeoylquinic acid 是一种有效的NF-κB 抑制剂,对 p105 的 RH 结构域显示高结合亲和力,Ki= 0.002 μM,结合能为 1.50 Kcal/mol。它抑制PD-1/PD-L1相互作用。它具有抗氧化应激能力。 | |||
T6S0071 |
Fraxinellone
|
HIF/HIF Prolyl-Hydroxylase; STAT; PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Immunology/Inflammation; JAK/STAT signaling; Metabolism; Stem Cells |
Fraxinellone 是从白鲜的根皮中分离出来的一种天然产物,是PD-L1抑制剂,可抑制HIF-1α蛋白质合成。它通过靶向 PD-L1,有用于癌症免疫的潜力。 | |||
T2763 |
Panaxadiol
人参二醇,20(R)-Panaxadiol |
Others; HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism; Others |
Panaxadiol (20(R)-Panaxadiol) 是从人参根中获得,具有神经保护和抗肿瘤作用,能够抑制程序性细胞死亡配体-1(PD-L1)的表达和肿瘤增殖。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05395 |
PD-1 Protein, Mouse, Recombinant (hFc)
Ly101,PD-1,programmed ce... |
Mouse | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-00996 |
PD-1 Protein, Mouse, Recombinant (His)
programmed cell death 1,Pdc1,Ly |
Mouse | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-05079 |
PD-1 Protein, Human, Recombinant (mFc)
PD-1,SLEB2,hSLE1,CD279,programmed... |
Human | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-00897 |
PD-1 Protein, Human, Recombinant (His)
PD1,hPD-l,hPD-1... |
Human | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-04898 |
PD-1 Protein, Human, Recombinant (hFc)
PD1,programmed cell death 1,P... |
Human | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-04967 |
PD-1 Protein, Mouse, Recombinant (His), Biotinylated
PD-1,programmed cell death 1,Ly |
Mouse | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-00896 |
PD-1 Protein, Human, Recombinant (His & hFc)
PD1,hPD-l,SLEB2,programmed cell d... |
Human | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPK-00181 |
PD-1 Protein (Primary Amine Labeling), Mouse, Recombinant (hFc), Biotinylated
SLEB2,PD-1,PDCD1,PD<... |
Mouse | HEK293 |
Programmed cell death protein 1, also known as PD-1 and CD279 , is a protein found on the surface of cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self tolerance by suppressing T cell inflammatory activity. | |||
TMPY-04343 |
PD-L1 Protein, Human, Recombinant (His)
PDL1,B7-H,B7H1,PDCD1... |
Human | HEK293 |
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 fa... | |||
TMPY-04949 |
PD-L1 Protein, Human, Recombinant (His), Biotinylated
PDCD1LG1,B7H1,PD |
Human | HEK293 |
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 fa... | |||
TMPK-00688 |
PD-1 Protein, Canine, Recombinant (aa 25-170, hFc)
CD279,PDCD1,SLEB2,PD1, |
Canine | HEK293 |
Programmed cell death protein 1, also known as PD-1 and CD279 , is a protein found on the surface of cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self tolerance by suppressing T cell inflammatory activity. | |||
TMPY-06336 |
PD-1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
SLEB2,hPD-1,programmed cell death 1 |
Human | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-05619 |
PD-1 Protein, Human, Recombinant (His), Biotinylated
hPD-l,PD-1,SLEB2,PD1... |
Human | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-05208 |
PD-L1 Protein, Human, Recombinant
CD274 molecule,PDCD1L1,PD |
Human | HEK293 |
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 fa... | |||
TMPY-05827 |
PD-L2 Protein, Human, Recombinant (mFc)
PDCD1L2,bA574F11.2,Btdc,... |
Human | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPK-00180 |
PD-1 Protein, Human, Recombinant (aa 25-167, hFc & Avi), Biotinylated
PD-1,PDCD1,CD279,SLEB2,<... |
Human | HEK293 |
Programmed cell death protein 1, also known as PD-1 and CD279 , is a protein found on the surface of cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self tolerance by suppressing T cell inflammatory activity. | |||
TMPY-04342 |
PD-1 Protein, Canine, Recombinant (His)
programmed cell death 1 |
Canine | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-05260 |
PD-1 Protein, Cynomolgus, Recombinant (His)
programmed cell death 1 |
Cynomolgus | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-04957 |
PD-L2 Protein, Human, Recombinant (His), Biotinylated
B7DC,Btdc,B7-DC,bA574F11.2,PDL2,p... |
Human | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPY-06682 |
PD-1 Protein, Human, Recombinant (Asp26-Pro39 deletion, His)
hPD-1,hSLE1,hPD-l,CD279,... |
Human | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-04346 |
PD-L2 Protein, Human, Recombinant (His)
PD-L2,B7-DC,CD273,Btdc,PDCD1L2,B7... |
Human | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPY-05815 |
PD-1 Protein, Canine, Recombinant (His & Avi), Biotinylated
programmed cell death 1 |
Canine | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-02512 |
Alpha-Synuclein Protein, Human, Recombinant
PD1,α-Synuclein,PARK4,synuclein, α (non A4... |
Human | E. coli |
Alpha-Synuclein (alpha-Syn), also known as NACP or SNCA, exists as at least two structural isoforms: one is helix-rich, membrane-bound form that both the N- and C-terminal regions of alpha-synuclein are tightly associated with membranes and the other is disordered, cytosolic form. Synuclein is found predominantly in the presynaptic termini, in both free or membrane-bound forms. SNCA is extensively localized in nucleus of neurons. It has been shown that alpha-Synuclein was highly expressed in the... | |||
TMPY-03219 |
VISTA Protein, Human, Recombinant (His)
DD1α,V-set immunoregulatory receptor,SISP1... |
Human | HEK293 |
VSIR (V-Set Immunoregulatory Receptor, also known as VISTA) is a Protein Coding gene. VISTA is an immunoregulatory receptor that inhibits the T-cell response. It may promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling. VSIR, or V-set immunoregulatory receptor, could be involved in the pathogenesis of chronic rhinosinusitis with nasal polyps. V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ a... | |||
TMPK-00182 |
PD-L1 Protein, Human, Recombinant (aa 19-238, His & Avi), Biotinylated
PDL1,PD-L1B7 homolog |
Human | HEK293 |
B7-H1, also known as PD-L1 and CD274, is an approximately 65 kDa transmembrane glycoprotein in the B7 family of immune regulatory molecules. PD-L1 has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. | |||
TMPK-00662 |
PD-L1 Protein (Primary Amine Labeling), Cynomolgus/Rhesus macaque, Recombinant (His), Biotinylated
PDCD1LG1,B7-H1,B7H1<... |
Cynomolgus,Rhesus macaque | HEK293 |
B7-H1, also known as PD-L1 and CD274, is an approximately 65 kDa transmembrane glycoprotein in the B7 family of immune regulatory molecules. PD-L1 has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. | |||
TMPY-05282 |
PD-L2 Protein, Mouse, Recombinant (His), Biotinylated
PD-L2,programmed cell death 1 ligand 2,B7-... |
Mouse | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPJ-00638 |
PD-L1 Protein, Cynomolgus, Recombinant (His)
B7-H,B7-H1,PDL1,PDCD... |
Cynomolgus | Human Cells |
CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells, PD-L1 may in... | |||
TMPJ-00637 |
PD-L1 Protein, Cynomolgus, Recombinant (hFc)
B7-H,PD-L1B7 homolog 1,Programmed... |
Cynomolgus | Human Cells |
CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells, PD-L1 may in... | |||
TMPY-02352 |
PD-L2 Protein, Mouse, Recombinant (His)
programmed cell death 1 ligand 2,Btdc,F73001 |
Mouse | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPY-02436 |
PD-L2 Protein, Mouse, Recombinant (hFc)
F730015O22Rik,Btdc,PD-L2,programmed cell d... |
Mouse | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPY-05238 |
PD-L1 Protein, Human, Recombinant (hFc), Biotinylated
PDL1,B7H1,PDCD1... |
Human | HEK293 |
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 fa... | |||
TMPY-02712 |
Serpin B3 Protein, Human, Recombinant (His)
T4-A,HsT1196,serpin peptidase inhibitor, c... |
Human | Baculovirus-Insect Cells |
SERPINB3, also known as SCCA-1, belongs to the serpin family. Serpins are a group of proteins with similar structures that were first identified as a set of proteins able to inhibit proteases. The acronym serpin was originally coined because many serpins inhibit chymotrypsin-like serine proteases. SERPINB3 is expressed in some hepatocellular carcinoma (at protein level). Its expression is closely related to cellular differentiation in both normal and malignant squamous cells. It seems to also be... | |||
TMPY-00633 |
PD-1 Protein, Rhesus, Recombinant (hFc)
programmed cell death 1 |
Rhesus | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-00250 |
PD-1 Protein, Rhesus, Recombinant (His)
programmed cell death 1 |
Rhesus | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-03717 |
PD-1 Protein, Rat, Recombinant (hFc)
programmed cell death 1 |
Rat | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-04648 |
PD-L1 Protein, Human, Recombinant (mFc)
CD274 molecule,B7-H1,PDL1,PD<... |
Human | HEK293 |
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 fa... | |||
TMPY-06276 |
PD-L1 Protein, Human, Recombinant (His & Avi), Biotinylated
PD-L1,PDL1,CD274 molecul... |
Human | HEK293 |
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 fa... | |||
TMPY-00676 |
PD-L1 Protein, Human, Recombinant (hFc)
PDCD1LG1,B7-H,PDCD1<... |
Human | HEK293 |
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 fa... | |||
TMPY-06281 |
PD-L2 Protein, Human, Recombinant (hFc & Avi), Biotinylated
bA574F11.2,B7DC,B7-DC,PDCD1 |
Human | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPJ-00183 |
PD-L1 Protein, Human, Recombinant (Flag)
B7-H1,Programmed Cell Death 1 Ligand 1... |
Human | Human Cells |
CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells, PD-L1 may in... | |||
TMPJ-00182 |
PD-L1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
B7-H1,PDCD1LG1,PD |
Human | Human Cells |
CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells, PD-L1 may in... | |||
TMPY-04341 |
PD-1 Protein, Rat, Recombinant (His)
programmed cell death 1 |
Rat | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPY-00233 |
PD-1 Protein, Canine, Recombinant (hFc)
programmed cell death 1 |
Canine | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
TMPK-01186 |
B7-H5/Gi24/VISTA Protein, Human, Recombinant (His)
VSIR,B7H5,4632428N05Rik,SISP1,PP2135,Dies<... |
Human | HEK293 |
B7-H5, also known as VISTA , B7H5, Dies1, SISP1 and C10orf54, is a 55-65 kDa member of the Ig superfamily. It is a transmembrane molecule expressed in bone, on embryonic stem cells (ESCs), and on tumor cell surfaces. | |||
TMPY-05184 |
VISTA Protein, Human, Recombinant (His), Biotinylated
DD1alpha,VISTA,B7H5,V-set immunoregulatory receptor... |
Human | HEK293 |
VSIR (V-Set Immunoregulatory Receptor, also known as VISTA) is a Protein Coding gene. VISTA is an immunoregulatory receptor that inhibits the T-cell response. It may promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling. VSIR, or V-set immunoregulatory receptor, could be involved in the pathogenesis of chronic rhinosinusitis with nasal polyps. V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ a... | |||
TMPY-00120 |
PD-L2 Protein, Human, Recombinant (hFc)
Btdc,B7-DC,programmed cell death 1 ligand 2,B7DC, |
Human | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPK-01185 |
B7-H5/Gi24/VISTA Protein, Human, Recombinant (hFc)
PP2135,SISP1,VISTA,Gi24,B7H5,4632428N05Rik... |
Human | HEK293 |
B7-H5, also known as VISTA , B7H5, Dies1, SISP1 and C10orf54, is a 55-65 kDa member of the Ig superfamily. It is a transmembrane molecule expressed in bone, on embryonic stem cells (ESCs), and on tumor cell surfaces. | |||
TMPY-05613 |
PD-L2 Protein, Human, Recombinant (His & Avi), Biotinylated
bA574F11.2,programmed cell death 1 |
Human | HEK293 |
Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B ... | |||
TMPY-00253 |
PD-1 Protein, Cynomolgus, Recombinant (hFc)
programmed cell death 1 |
Cynomolgus | HEK293 |
Programmed cell death 1, also known as PDCD1, is a type I transmembrane glycoprotein, and is an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting protein tyrosine phosphatase, SHP-2 upon interacting with either of two ligands, PD-L1 or PD-L2. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, c... | |||
------------------------ 更多 ------------------------ |